Articles On Polynovo (ASX:PNV)

One of the standout performers on the S&P/ASX 200 index this year has been the Afterpay Touch Group Ltd (ASX: APT) share price. Since the start of the year the payments company’s shares have rallied an incredible 185% higher. This make...

Nearmap Ltd (ASX: NEA) and PolyNovo Limited (ASX: PNV) are the newest additions to my growth share watchlist. If you had held these 2 stocks since the beginning of the year, you would have seen a healthy growth in your portfolio of 167%. H...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The iSignthis Ltd (ASX: ISX) share price is up an amazing 8.5x in 2019 alone from 16 cents to $1.37 today despite the payments and ID verifier posting a marginally widening loss of $729,190 on sales revenue of $7.47 million for the half-ye...

Zip Co Ltd (ASX: Z1P) and Bubs Australia Ltd (ASX: BUB) just made it into the ASX 300 as part of the S&P Dow Jones Indices’ quarterly rebalance. S&P Dow Jones Indices is a division of credit ratings agency S&P Global. S&P Do...

A number of shares could be on the move on Friday after S&P Dow Jones Indices announced its September 2019 quarterly rebalance of the S&P/ASX Indices. Below is a summary of the changes that have been made, effective at the open of...

I have long considered the healthcare industry as being one of the best areas to invest in for the long term. Our population is living longer and healthier lives than ever before, and this brings opportunities that could last decades. CSL...

Mid-cap shares tend to offer investors the best potential returns on a risk-adjusted basis as they’re usually already profitable, but still small enough for them to double profits or market cap in as little as 12 months for example. It’s a...

The ASX 200 has seen phenomenal growth names emerge in 2019, but such explosive share price gains can also warrant some questioning as to whether these shares are overvalued. Investors are often faced with the difficult challenge of analys...

The Polynovo Ltd (ASX: PNV) share price closed at $2.10 yesterday – which caps off a huge run for the stock over the past week. Last Thursday, PNV shares were going for $1.59 so yesterday’s closing price represents a 32.1% gain since then....

With reporting season sprinting to the end, on a fundamental level it is not all doom and gloom, there are winners (and losers). We notice a clear winner in companies with direct consumer exposure. What are our observations on the cyclical...

Coming after trial flops from Factor Therapeutics (ASX:FTT), Innate Immunotherapeutics (now Amplia Therapeutics, ASX:ATX) and Bionomics (ASX:BNO), investors were awaiting the phase IIb results from the eye diseases house with more than a de...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

One way to find stock ideas is to use a screen to look for companies that have performed well over the past year. In theory shares performing well in the mid-cap space should still have plenty of room to grow, while not being so small that...

The PolyNovo Ltd (ASX: PNV) share price was amongst the best performers on the All Ordinaries index on Thursday. The medical device company’s shares were up over 10% at one stage before ending the day 9% higher at $1.60. Why did the PolyNo...

The PolyNovo Ltd (ASX:PNV) share price is trading higher today following an announcement from the company. What did PolyNovo announce? Earlier today PolyNovo released a trading update to the market regarding the company’s earnings and sale...

The best performer on the All Ordinaries index on Thursday has been the Wellcom Group Limited (ASX: WLL) share price. In late morning trade the Australian production and content management company’s shares are up over 28% to $6.76. Why is...

The Pro Medicus Limited (ASX: PME) share price hit a record high of $30.28 this morning despite it being labelled a ‘speculative bubble’ by high profile funds management team Forager Funds alongside 1o other companies with market values gr...

The biotechnology sector is one of those sectors that presents an incredible opportunity for huge returns to investors. This is because the business of curing diseases can be lucrative, and any company with a small market capitalisation can...

A lot of debate has emerged recently over why growth shares have tended to outperform value shares with the low interest rate environment worldwide one obvious reason. As interest or risk free rates on cash or other risk free assets like U...

Buying a piece of ownership in a company, given that the world stock markets are gushing with lucrative options every day, can be a daunting task for the investors. Keeping diversification as the fundamental strategy, allocating some portio...

Here’s one that investors can really get their teeth into: Orthocell’s (ASX:OCC) regenerative therapy Celgro quickens and improves dental implant procedures and repairs jangled nerves in more ways than one. To the joy of Collingwood support...

The PolyNovo Ltd  (ASX: PNV) share price has been amongst the best-performers on the Australian share market over the last 12 months. On Monday the medical device company’s shares hit a multi-year high of $1.59, which stretched their 12-mon...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...

The Gent's Manifesto: My Journey And Investment Philosophy Ethical Equities Founder, Claude Walker has suggested that I share with readers some background on my investing journey to date. This is my own fault and the just desserts for my h...